No indicado para nios ni personas de edad avanzada
These effects may include a notable increase in appetite
At present, the evidence remains insufficient to recommend GLP-1 receptor agonists specifically for neurodegenerative disease management
Anyone currently being treated for cancer, known allergy to injections, or with a history of fainting with injections should not get a Voda Health shot
Challenges include gastrointestinal side effects, nutritional deficiencies due to calorie reduction, muscle and bone loss, low long-term adherence with subsequent weight regain, and high costs, resulting in low cost-effectiveness
--- Dosing Protocol Standard Research Dosing Ipamorelin: 200300 mcg per injection CJC-1295 (no DAC): 100200 mcg per injection Both are administered together via subcutaneous injection